Share: Facebook Twitter LinkedIn
Activity Provided By:

Relias LLC

An Innovative View: Evaluating Combination Checkpoint Inhibition Strategies in Advanced Melanoma: Considerations with Anti-LAG3 Antibodies

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of oncologists, dermatologists, nurse practitioners, oncology pharmacists, and physician assistants to ensure confidence in the management of advanced melanoma.

Program Overview
This online program is designed to help oncologists, dermatologists, nurse practitioners, oncology pharmacists, and physician's assistants to ensure confidence in the management of advanced melanoma. We aim to evaluate the pathophysiology of melanoma, including the rationale for use of anti-LAG3 antibodies in combination in advanced melanoma; assess the latest clinical data and clinical trial opportunities concerning the use of anti-LAG3 antibodies for combination in advanced melanoma; and recognize safety data with combination immunotherapy approaches in advanced melanoma.

Learning Objectives
Upon completion of this activity, participants should be better able to:
Evaluate the pathophysiology of melanoma, including the rationale for use of anti-LAG3 antibodies in combination in advanced melanoma
Assess the latest clinical data and clinical trial opportunities concerning the use of anti-LAG3 antibodies for combination in advanced melanoma
Recognize safety data with combination immunotherapy approaches in advanced melanoma

Expiration

Mar 08, 2024

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Allison Betof Warner, MD, PhD
Assistant Attending Physician
Melanoma Service, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
New York, NY

Sponsors / Supporters / Grant Providers

Med Learning Group; AMEDCO; Regeneron Pharmaceuticals, Inc.

Keywords / Search Terms

Relias LLC Oncology, Dermatology, Melanoma Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map